Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03570476
What this trial is testing

Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma Without Neuroendocrine DifferentiationStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+3 more
University of Washington 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899987
What this trial is testing

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+7 more
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT01505868
What this trial is testing

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaLymphadenopathy+4 more
M.D. Anderson Cancer Center 170
Testing effectiveness (Phase 2)Study completedNCT01120236
What this trial is testing

Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
National Cancer Institute (NCI) 211
Not applicableLooking for participantsNCT04545957
What this trial is testing

Jump: MR Simulation For Radiation Therapy Master Protocol

Who this might be right for
Prostate CancerRecurrent AdenocarcinomaLiver Cancer+1 more
Brigham and Women's Hospital 86
Testing effectiveness (Phase 2)Looking for participantsNCT05691465
What this trial is testing

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Who this might be right for
Metastatic Prostate Adenocarcinoma With Neuroendocrine DifferentiationMetastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Small Cell Neuroendocrine Carcinoma+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00217516
What this trial is testing

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 18
Early research (Phase 1)Active Not RecruitingNCT01655836
What this trial is testing

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 42
Testing effectiveness (Phase 2)Ended earlyNCT00084864
What this trial is testing

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT00728663
What this trial is testing

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 35
Not applicableStudy completedNCT00535834
What this trial is testing

Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 48
Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00400517
What this trial is testing

GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
The Cleveland Clinic 28
Testing effectiveness (Phase 2)Study completedNCT00524680
What this trial is testing

Vitamin D in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 148
Testing effectiveness (Phase 2)Looking for participantsNCT06499870
What this trial is testing

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Who this might be right for
Prostate Adenocarcinoma
Sean Sachdev 50
Testing effectiveness (Phase 2)WithdrawnNCT00084565
What this trial is testing

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951
What this trial is testing

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more
Jonsson Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01228084
What this trial is testing

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
OHSU Knight Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT00936390
What this trial is testing

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,538
Next Page
35